Mortality Rate Trends for Sickle Cell Disease and Cystic Fibrosis in the US.
作者信息
Abraha Hiluf Ebuy, Thoma Marie, Boghossian Nansi S
机构信息
Department of Epidemiology and Biostatistics, University of South Carolina, Columbia.
Department of Family Science, School of Public Health, University of Maryland, College Park.
出版信息
JAMA Pediatr. 2025 Sep 8. doi: 10.1001/jamapediatrics.2025.2997.
Abstract
摘要
相似文献
1
Mortality Rate Trends for Sickle Cell Disease and Cystic Fibrosis in the US.美国镰状细胞病和囊性纤维化的死亡率趋势
JAMA Pediatr. 2025 Sep 8. doi: 10.1001/jamapediatrics.2025.2997.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰萨二氏病的孕前风险评估。
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
5
Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.用于预防12岁及以下高危儿童下呼吸道感染的抗生素。
Cochrane Database Syst Rev. 2015 Sep 26;2015(9):CD011530. doi: 10.1002/14651858.CD011530.pub2.
6
Magnesium for treating sickle cell disease.镁用于治疗镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 14;4(4):CD011358. doi: 10.1002/14651858.CD011358.pub2.
7
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
8
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.血管紧张素转换酶（ACE）抑制剂治疗镰状细胞病患者的蛋白尿和微量白蛋白尿。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD009191. doi: 10.1002/14651858.CD009191.pub4.
9
Interventions for treating leg ulcers in people with sickle cell disease.镰状细胞病患者腿部溃疡的治疗干预措施。
Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD008394. doi: 10.1002/14651858.CD008394.pub3.
10
Blood transfusions for treating acute chest syndrome in people with sickle cell disease.输血治疗镰状细胞病患者的急性胸部综合征。
Cochrane Database Syst Rev. 2016 Aug 30(8):CD007843. doi: 10.1002/14651858.CD007843.pub3.
本文引用的文献
1
Sickle cell treatment removed from market.
Am J Nurs. 2025 Mar 1;125(3):18. doi: 10.1097/AJN.0000000000000024. Epub 2025 Feb 20.
2
Cell and Gene Therapies - Improving Access and Outcomes for Medicare and Medicaid Beneficiaries.细胞与基因疗法——改善医疗保险和医疗补助受益人的可及性与治疗效果
N Engl J Med. 2025 Feb 6;392(6):521-523. doi: 10.1056/NEJMp2412955. Epub 2025 Feb 1.
3
The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease.镰状细胞病基因疗法极高价格的双刃剑
JAMA. 2024 Sep 3;332(9):703-704. doi: 10.1001/jama.2024.11703.
4
Comparison of US Federal and Foundation Funding of Research for Sickle Cell Disease and Cystic Fibrosis and Factors Associated With Research Productivity.比较美国联邦政府和基金会对镰状细胞病和囊性纤维化研究的资助，以及与研究生产力相关的因素。
JAMA Netw Open. 2020 Mar 2;3(3):e201737. doi: 10.1001/jamanetworkopen.2020.1737.
Zotero 插件